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We have studied the synergistic effects of squalene and polyunsaturated fatty acids (PUFA 
concentrate) on isoprenaline-induced infarction in rats with respect to changes in the levels of plasma 
diagnostic marker enzymes and myocardial antioxidant defense system. Intraperitoneal injection of 
isoprenaline caused a significant elevation in the levels of diagnostic marker enzymes; alanine 
aminotranferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and creatine 
phosphokinase (CPK) in plasma of experimental rats. There was a significant rise in the level of lipid 
peroxidation with concomitant decline in the level of reduced glutathione (GSH) and in the activities of 
glutathione-dependent antioxidant enzymes; glutathione peroxidase (GPX) and glutathione-S-
transferase (GST), and antiperoxidative enzymes; superoxide dismutase (SOD) and catalase (CAT) in 
heart tissue. Combined supplementation of squalene and PUFA concentrate significantly prevented the 
isoprenaline-induced elevations in the levels of diagnostic marker enzymes in plasma of experimental 
groups of rats. A tendency to counteract the isoprenaline induced lipid peroxidation was also noticed. 
Their combined administration maintained the level of GSH and the activities of glutathione-dependent 
antioxidant enzymes and antiperoxidative enzymes at near normalcy. The results of the present study 
indicated that the combined administration of squalene and PUFA concentrate exerted significantly 
better cardio-protection against isoprenaline-intoxication as compared to that of per second 
supplementation. 
 





Cardiovascular diseases form a major health concern in 
recent years, causing severe illness and death through-
out the world. According to the statistics given by WHO 
(2004) about 16.7 million people around the globe die of 
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third of the total global deaths. It is predicted that heart 
disease and stroke will become the leading cause of 
death and disability world-wide by the year 2020, with the 
number of fatalities projected to increase more than 20 
million a year and to more than 24 million a year by 2030. 
The developing countries like India are struggling to 
manage the impact of infectious diseases along with the 
growing burden on society and health systems caused by 
non-communicable diseases such as myocardial infar-
ction (Farvin et al., 2004). Moreover, it is very much pain- 




ful and of serious concern to realize that myocardial 
infarction in India occurs 10 to 15 years earlier as 
compared to that of the west. It is also important to note 
that an increasing number of young Indians are falling 
prey to myocardial infarction, and there are an estimated 
45 million patients of coronary heart disease in India 
(Krishnaswami, 1998). Current projections suggest a 
highly notorious, but a real fact that by the year 2020 
India will have the largest cardiovascular disease burden 
in the world (Yusuf et al., 2001). 
Epidemiological studies (Das, 2000; Okuda et al., 
2005) have revealed that Greenland Eskimos and 
Japanese with diets rich in fish oil show low incidence of 
ischemic heart disease as compared with European and 
North American populations. Prospective studies (Holub 
and Holub, 2004; Mori and Beilin, 2004) show that there 
is an inverse relation between fish intake and mortality 
from coronary heart disease. It is hypothesized that the 
highly unsaturated fatty acids, eicosapentaenoic acid 
(EPA, C20:5n-3) and docosahexaenoic acid (DHA, 
C22:6n-3) present in substantial quantities in Mediterra-
nean diet are the active components responsible for this 
beneficial effect. However, it is very much important to 
realize the fact that PUFA are well known for their 
peroxidative property, which is highly deleterious to the 
stabilization of cellular and subcellular membranes. 
Earlier reports by Anandan et al. (2003) indicate that 
supplementation of peroxidized PUFA accelerates the 
experimental induction of myocardial infarction in rats. 
Interestingly, squalene, an isoprenoid antioxidant mole-
cule, which also comprises a major portion in Mediterra-
nean diet, has not yet been considered in par with EPA 
and DHA for its beneficial effects on myocardial function. 
It is present in large quantities in deep-sea shark liver oil 
and in smaller amounts (0.1 - 0.7%) in palm oil, wheat-
germ oil, olive oil, and rice-bran oil (Liu et al., 1976) and 
has been reported to possess antilipidemic, antioxidant 
and membrane-stabilizing properties (Qureshi et al., 
1996; Ko et al., 2002; Ivashkevich et al., 1981). Further, it 
is directly involved in the lipid metabolism not only as a 
precursor molecule of cholesterol biosynthesis, but also 
as a feed back inhibitor of HMG CoA reductase, a key 
enzyme regulating the cholesterol metabolism in living 
beings (Sawada et al., 2001). It plays an important role in 
enhancing health through its part in the building blocks of 
hormones and cholesterol, and as antioxidant. Squalene 
is secreted in human serum, where it protects the skin 
from ultraviolet radiation (Kohno et al., 1995). Storm et al. 
(1993) demonstrated the protective activity of squalene 
against radiation-induced injury in a mouse model. 
Several experimental models (Fan et al., 1996; Kamim-
ura et al., 1992) demonstrated the detoxifying activities of 
squalene against diverse chemicals such as hexachloro-
biphenyl, hexachlorobenzene, arsenic, theophylline, 
phenobarbital and strychnine. Squalene has also been 
found to have protective activity against several carcino- 





Table 1. Fatty acid composition of PUFA 
concentrates prepared from fish oil. 
 
Fatty acids  Percentage (%) 
C16:0 5.74 
C18:0 2.91 
C16:1 n-7 3.58 
C18:1 n-9 5.52 
C20:4 n-6 9.74 
C20:5 n-3 27.5 





(Rao et al., 1998) and nicotine-derived nitro-
saminoketone-(NMK) induced lung carcinogenesis (Smith 
et al., 1998). Since squalene is being one of the most 
powerful antioxidant and antilipidemic agents, it has to be 
studied in detail as an important compound for better 
medicinal values. 
In the present study, we have investigated the synergi-
stic effects of squalene and PUFA concentrate on myo-
cardial antioxidant status in isoprenaline-induced myocar-
dial infarction in rats, an animal model of myocardial 
infarction of human beings. 
 
 




Epinephrine, tetraethoxy propane and reduced glutathione were 
obtained from M/s. Sigma Chemical Company, St. Louis. MO, USA. 
Squalene (Specific gravity: 0.853; refractive index: 1.493; 
saponification value: 30; iodine value: 344; boiling point: 240 - 
245ºC) was prepared from the shark liver oil of Centrophorus sp. 
caught in the Andaman waters (Farvin et al., 2004). PUFA 
concentrate (Table 1) used in this study was prepared from fish oil 
in our laboratory by removing the major part of saturated and 
monounsaturated fractions as urea inclusion complexes using a 
modified procedure of Ackman et al. (1988). All the other chemicals 





Wistar strain male albino rats, weighing 120 – 150 g were selected 
for the study. The animals were housed individually in polyurethane 
cages under hygienic conditions and maintained at normal room 
temperature. The animals were allowed food and water ad libitum. 
The experiment was carried out as per the guidelines of Committee 
for the Purpose of Control and Supervision of Experiments on 
Animals (CPCSEA), New Delhi, India. 
 
 
Induction of myocardial infarction 
 
The myocardial infarction was induced in experimental rats by 
injecting isoprenaline [11 mg (dissolved in physiological saline) 100 
g-1 body weight day-1], i.p. for 2 days (Anandan et al., 2003). 




Table 2. Levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and creatine 
phosphokinase (CPK) in plasma of normal and experimental groups of rats. 
 
Groups Group 1a Group 1b Group 2a Group 2b Group 3a Group 3b Group 4a Group 4b 
ALT 88.3 ± 6.43 345 ± 29.4a 84.2 ± 6.94 132 ± 9.78b,c 98.7 ± 7.18 165 ± 12.5b,d 85.6 ± 6.21 104 ± 8.62b,e 
AST 98.1 ± 7.94 383 ± 26.8a 87.7 ± 6.86 155 ± 10.4b,c 110 ± 8.24 167 ± 11.9b,d 89.5 ± 6.76 112 ± 7.11b,e 
LDH 121 ± 9.52 296 ± 18.9a 118 ± 8.76 139 ± 12.4b,c 135 ± 14.1 157 ± 9.87b,d 115± 8.59 129 ± 9.34b,e 
CPK 107 ± 8.27 297 ± 23.4a 105 ± 7.12 129 ± 9.7b,c 118 ± 9.45 143 ± 10.4b,d 98.7 ± 7.93 123 ± 8.76b,e 
 
Group 1a, 2a, 3a and 4a, were normal control rats, received standard diet mixed with coconut oil, squalene, PUFA concentrate and squalene + PUFA 
concentrate, respectively, at 2% level for a period of 60 days and then intraperitoneally (i.p.) injected with physiological saline for 2 days. 
Group 1b, 2b, 3b and 4b, were experimental rats, received standard diet mixed with coconut oil, squalene, PUFA concentrate and squalene + PUFA 
concentrate respectively at 2% level for a period of 60 days and then intraperitoneally (i.p.) injected with isoprenaline [11 mg (dissolved in physiological 
saline) 100 g-1 body weight day-1 for 2 days] for the induction of myocardial infarction. 
Results are mean ± SD of six animals. Values expressed: ALT, AST, and LDH, mol pyruvate liberated h-1l-1; CPK, mol creatine liberated h-1l-1. 
aP<0.001 significantly different compared with Group1a control animals; bP<0.001 significantly different compared with Group1b isoprenaline-
administered rats; cP<0.001 significantly different compared with Group2a squalene fed normal rats; dP<0.001 significantly different compared with 
Group3a PUFA concentrate supplemented control animals; eP<0.001 significantly different compared with Group 4a squalene + PUFA concentrate 






Five days after acclimatization, the animals were divided into four 
groups of 12 rats each. Group 1, 2, 3 and 4 animals were fed on 
commercial feed with added coconut oil, squalene, PUFA concen-
trate and squalene + PUFA concentrate, respectively, at 2% level 
for 60 days. After 60 days, the rats were further subdivided into 
eight groups [Group 1a and 1b; 2a and 2b; 3a and 3b; and 4a and 
4b] of 6 rats each. Group 1b, 2b, 3b, 4b animals were intraperito-
neally (i.p.) injected with isoprenaline [11 mg (dissolved in physio-
logical saline) 100 g-1 body weight day-1 for 2 days] for the induction 
of myocardial infarction. Control animals [Group 1a, 2a, 3a and 
Group 4a] were i.p. injected with physiological saline alone for 2 
days. 
At the end of the experimental period, i.e., 24 h after last injection 
of isoprenaline, the experimental animals were killed, blood was 
collected using sodium citrate as anticoagulant and the plasma 
separated was used for the determination of diagnostic marker 
enzymes. The heart tissue was excised immediately and washed 
with chilled isotonic saline. The heart tissue homogenates prepared 
in ice cold 0.1 M Tris-HCl buffer, pH 7.2 were used for the deter-




Biochemical assays  
 
The activities of alanine aminotransferase [EC 2.6.1.2] (ALT) and 
aspartate aminotransferase [EC 2.6.1.1] (AST) in plasma were 
determined spectrophotometrically by the method of Mohur and 
Cook (1957). The lactate dehydrogenase (EC 1.1.1.27) (LDH) 
activity in plasma was assayed according to the method of King 
(1965). The creatine phosphokinase [EC 2.7.3.2] (CPK) activity in 
plasma was determined by the method of Okinaka et al. (1961). 
Tissue lipid peroxide level was determined as TBA-reactive 
substances (Ohkawa et al., 1979). GSH was determined by the 
method of Ellman, (1959). Glutathione peroxidase (EC 1.11.1.9) 
(GPx) activity was measured by the method of Paglia and 
Valentine, (1967). Glutathione-S-transferase (EC 2.5.1.18) (GST) 
activity was determined by the method of Habig et al. (1974). 
Catalase (EC 1.11.1.6) (CAT) activity was assayed according to the 
method of Takahara et al. (1960). Superoxide dismutase activity 
was determined according to the method of Misra and Fridovich 
(1972) based on the oxidation of epinephrine-adrenochrome 
transition by the enzyme.  
Statistical analysis 
 
Results are expressed as mean ± SD. One-way analysis of 
variance (ANOVA) was carried out, and the statistical comparisons 
among the groups were performed with Tukey’s test using a 





Table 2 depicts the levels of diagnostic markers (AST, 
ALT, LDH and CPK) in the plasma of normal and experi-
mental groups of rats. There was a significant (p<0.001) 
increase noticed in the levels of these specific diagnostic 
markers in plasma of Group 1b myocardial infarction 
induced rats as compared to that of Group 1a control 
rats. In Group 4b rats, the combined supplementation of 
squalene and PUFA concentrate significantly (p<0.001) 
reduced the release of these enzymes from the myocar-
dium into the systemic circulation and maintained the rats 
at near normal status, indicating the cytoprotective action 
of squalene and PUFA concentrate. Moreover, it is very 
much interesting to note that the combination exerted 
significantly a better protection as compared to that of 
Group 2b squalene supplemented and Group 3b PUFA 
concentrate supplemented rats. 
Table 3 shows the levels of lipid peroxides and reduced 
glutathione and the activities of glutathione dependent 
antioxidant enzymes (GPx and GST) and antiperoxidative 
enzymes in the heart tissue of normal and experimental 
groups of rats. There was a significant (p<0.001) increase 
in the level of lipid peroxidation along with a concomitant 
decline in the level of GSH noted in the heart tissue of 
Group 1b isoprenaline-administered rats as compared to 
Group 1a controls. Also a significant (p<0.001) reduction 
in the activities of glutathione dependent antioxidant 
enzymes (GPx and GST) and antiperoxidative enzymes 
(SOD and CAT) was observed. The combined adminis-
tration of squalene and PUFA concentrate in Group 4b 
rats  significantly  reduced  the  isoprenaline  induced  ad-  




Table 3. Levels of lipid peroxides (LPO) and reduced glutathione (GSH) and the activities of glutathione peroxidase (GPx), glutathione-S-
transferase (GST), catalase (CAT) and superoxide dismutase (SOD) in the heart tissue of normal and experimental groups of rats. 
 
Groups Group Ia Group Ib Group IIa Group IIb Group IIIa Group IIIb Group IVa Group IVb 
LPO 1.15 ±0.08 2.39± 0.16a 0.91 ±0.06 1.08 ±0.08b,c 1.52 ±0.11 2.21± 0.14b,d 1.02 ±0.06 1.12±0.07b,e 
GSH 4.24 ± 0.31 2.15 ± 0.15a 4.53 ± 0.28 3.92 ± 0.35b,c 5.12 ± 0.42 3.57 ± 0.22b,d 4.76 ± 0.34 4.68 ± 0.31b,e 
GPX 2.55 ± 0.24 1.32 ± 0.11a 2.45 ± 0.21 2.18 ± 0.15b,c 2.86 ± 0.22 1.93 ± 0.15b,d 2.81 ± 0.24 2.77 ± 0.15b,e 
GST 1167 ± 79 723 ± 58a 1231 ± 87 1124 ± 82b,c 1457 ± 118 1098 ± 74b,d 1296 ± 102 1231 ± 108b,e 
SOD 4.76 ± 0.33 2.04 ± 0.17a 4.51 ± 0.28 3.97 ± 0.25b,c 5.65 ± 0.42 3.78 ± 0.12b,d 4.97 ± 0.31 4.85 ± 0.27b,e 
CAT 7.83 ± 0.49 3.15 ± 0.19a 7.68 ± 0.52 6.98 ± 0.44b,c 8.72 ± 0.52 5.94 ± 0.43b,d 8.31 ± 0.55 8.24 ± 0.52b,e 
 
 
Group 1a, 2a, 3a and 4a, were normal control rats, received standard diet mixed with coconut oil, squalene, PUFA concentrate and squalene + PUFA 
concentrate, respectively, at 2% level for a period of 60 days and then intraperitoneally (i.p.) injected with physiological saline for 2 days 
Group 1b, 2b, 3b and 4b, were experimental rats, received standard diet mixed with coconut oil, squalene, PUFA concentrate and squalene + PUFA 
concentrate respectively at 2% level for a period of 60 days and then intraperitoneally (i.p.) injected with isoprenaline [11 mg (dissolved in physiological 
saline) 100 g-1 body weight day-1 for 2 days] for the induction of myocardial infarction. 
Results are mean ± SD for 6 animals. Values expressed: LPO, nmol malondialdehyde released/mg protein; GSH, µmol g-1 wet tissue; GPx, nmol GSH 
oxidized min-1 mg-1 protein; GST, mol 1-chloro-2, 4-dinitrobenzene conjugate formed min-1 mg-1 protein; CAT, nmol H2O2 decomposed min-1 mg-1 
protein; SOD, one unit of the SOD activity is the amount of protein required to give 50% inhibition of epinephrine autoxidation. aP<0.001 significantly 
different compared with Group1a control animals; bP<0.001 significantly different compared with Group1b isoprenaline-administered rats; cP<0.001 
significantly different compared with Group2a squalene fed normal rats; dP<0.001 significantly different compared with Group 3a PUFA concentrate 




verse effects and maintained the levels of evaluated 
parameters at near normalcy. But in the case of PUFA 
concentrate supplemented Group 3a rats, significant 
elevation in the levels of lipid peroxidation and GSH 
content was noticed. However, slight raise in the activities 
of antioxidant enzymes was also noticed. Though some 
amount of protective action on the antioxidant system 
was noticed with the per second supplementation of 
squalene and PUFA concentrate in Group 2b and 3b rats 
respectively, it is well evident from the present observa-
tion that the supplementation of both in combination offer 
comparatively better beneficial effects in ameliorating 





Significant (p<0.001) rise noted in the levels of AST, ALT, 
LDH and CPK in plasma of Group 1b isoprenaline 
intoxicated rats, which are well known diagnostic markers 
of myocardial infarction, is an indicative of the extent of 
isoprenaline-induced formation of necrotic lesions in the 
myocardium. This present observation is in line with 
earlier reported studies (Farvin et al., 2004; Anandan, 
2003), which have shown that the amount of diagnostic 
markers present in plasma is directly proportional to the 
number of necrotic cells present in the cardiac tissue. Of 
all the macromolecules that leak from the necrotic myo-
cardium, these markers because of their tissue specificity 
and catalytic activity are the best indicators of cardiac 
damage. Increased release of these diagnostic markers 
from the infarcted myocardium into systemic circulation 
observed in the present study reflects non-specific altera-
tions in the myocardial membrane integrity and permea-
bility as a response to β-adrenergic stimulation. 
Cell membranes are rich sources of PUFA and incurpo- 
ration of PUFA in membrane phospholipids influence 
membrane stabilization by modulating the fluidity of the 
myocardial membrane (Kim et al., 2000). However, it is 
also important to note that the presence of highly unsatu-
rated PUFA makes the myocardial membrane easily 
susceptible to oxy radicals-induced necrotic damage, 
resulting in increased release of diagnostic markers into 
the blood, as observed in the present study. Earlier 
Anandan et al. (2003) have reported that peroxidised 
PUFA intake is highly deleterious to myocardial mem-
brane stability. In the present study, it is observed that 
the combined supplementation of squalene and PUFA 
concentrate along with feed significantly (p<0.001) 
prevented the isoprenaline-induced elevation in the levels 
of diagnostic markers as compared to that of Group 1b 
myocardial infarcted rats. The presence of PUFA in cell 
membrane plays a major role in inhibition of cell volume 
reduction by modulating the elasticity of plasma mem-
brane (Sanchez-Olea et al., 1995). Cell volume affects 
the most basic processes of cell function, and as such it 
exerts an important role in the onset, severity, and 
outcome of myocardial infarction. An earlier reported 
study (Ivashkevich et al., 1981) indicates that squalene 
can overt severe osmolar changes associated with 
possible cell death. Reports by Farvin et al. (2004) have 
showed that the highly lipophilic squalene easily inter-
calates into the lipid matrix and imparts stabilization to 
myocardial cell membranes. 
Biological membranes are sensitive to lipid peroxidation 
induced by reactive oxygen species. Lipid peroxidation of 
membranes is regulated by the availability of substrate in 
the form of PUFA, the availability of inducers such as free 
radicals and excited state molecules to initiate propa-
gation, the antioxidant defense status of environment, 
and the physical status of the membrane lipids (Anandan 





xidation was significantly (p<0.001) elevated in the heart 
tissue of Group 1b myocardial infarction induced rats as 
compared to that of Group 1a control rats. The unpaired 
electron present in the hydroxyl free radical, which is res-
ponsible for isoprenaline-induced lipid peroxidation 
(Paradies et al., 1999), reacts with polyunsaturated fatty 
acids to form reactive lipid radicals harmful to the 
structural and functional integrity of the myocardial mem-
brane. Lipid peroxidation worsens the myocardial injury. 
The oxidative destruction of PUFA present in cell 
membrane phospholipids proceeds as a self-perpetual 
reaction. The significant (p<0.001) elevation noted in the 
level of lipid peroxidation in Group 3a and 3b rats as 
compared to that of Group 2a and 1a rats suggests the 
enhanced susceptibility of PUFA rich myocardial mem-
brane for peroxidative damage. This concurs with an 
earlier reported study (Ando et al., 2000), which indicates 
that supplementation of PUFA along with feed results in 
increased level of lipid peroxidation in tissues. 
In the present study, the combined administration of 
squalene and PUFA concentrate resulted in significant 
(p<0.001) reduction in the level of lipid peroxidation in the 
heart tissue towards near normalcy as compared to 
Group 1b isoprenaline-administered animals. The anti-
oxidant effect is probably due to the presence of 
isoprenoid unit in the structure of squalene. It probably 
did so by counteracting the free radicals produced as a 
result of both isoprenaline administration and PUFA 
intake. Squalene is not very susceptible to peroxidation 
and appears to function as a quencher of singlet oxygen, 
protecting cells from oxidative damage (Kohno et al., 
1995). In vitro experimental evidence indicates squalene 
is a highly effective oxygen-scavenging agent (Saint-
Leger et al., 1986). Reports by Miyachi et al. (1983) ind-
icate that subsequent to oxidative stress, such as sunlight 
exposure, squalene functions as an efficient quencher of 
singlet oxygen and prevents the corresponding lipid 
peroxidation in human skin surface. The rate constant of 
quenching of singlet oxygen by squalene is much larger 
than those of other lipids, and to be comparable to 3, 5-
di-t-butyl-4-hydroxytolene (BHT). Hence it is possible that 
the chain reaction of lipid peroxidation in PUFA rich 
myocardial membrane is unlikely to be propagated in the 
myocardium with the presence of adequate level of 
squalene. 
Oxidative stress is one of the mechanisms with a 
central role involved in the pathogenesis of myocardial 
infarction (Grieve et al., 2004). The oxidation of unsa-
turated fatty acids in biological membranes may cause 
impairment of membrane function, decrease in memb-
rane fluidity, inactivation of membrane receptors and 
enzymes, increase of non-specific permeability to ions 
and disruption of myocardial membrane structure 
(Anandan et al., 2003). Free radical scavenging enzymes 
such as catalase, superoxide dismutase, glutathione 
peroxidase and glutathione-S-transferase are the first line 
cellular defense against oxidative injury, decomposing O2  




and H2O2 before interacting to form the more reactive 
hydroxyl radical (OH•). The equilibrium between these 
enzymes is an important process for the effective rem-
oval of oxygen stress in intracellular organelles. 
Glutathione plays an important role in the regulation of 
variety of cell function and in cell protection from oxida-
tive injury. In the present study, significant (p<0.001) 
reduction in the activities of glutathione-dependent 
antioxidant enzymes (GPX and GST) and antiperoxi-
dative enzymes (SOD and CAT) with a concomitant 
decline in the level of reduced glutathione was observed 
in the heart tissue of Group 1b myocardial infarcted rats 
as compared to Group 1a normal control animals, 
reflecting an increased oxidative stress in isoprenaline-
induced myocardial injury. This is in accordance with 
previous investigations (Sathish et al., 2003; Shiny et al., 
2005), which indicated that the tissue antioxidant status 
was being operated at diminished level in isoprenaline-
induced myocardial infarction condition. Depletion of 
GSH results in enhanced lipid peroxidation, and 
excessive lipid peroxidation can cause increased GSH 
consumption (Anandan et al., 2003), as observed in the 
present study. Lowered activities of these prime 
antioxidant enzymes may lead to the formation of O2
- and 
H2O2, which in turn can form hydroxyl radical (OH•) and 
bring about a number of reactions harmful to the cellular 
and subcellular membranes in the heart tissue. Reduction 
noticed in the activities of the antiperoxidative enzymes in 
isoprenaline-induced myocardial infarction might be due 
to the increased generation of reactive oxygen radicals 
such as superoxide and hydrogen peroxide, which in turn 
lead to the inactivation of these enzyme activities. 
It is very much interesting to note that the level of GSH 
and the activities of these myocardial antioxidant 
enzymes are slightly higher  in Group  3a  PUFA  concen-
trate administered rats as compared to that of Group 1b 
control rats. This may be adoptive mechanism to amelio-
rate the PUFA-mediated peroxidation in the myocardium. 
Antioxidants are necessary for preventing the formation 
of free radicals and they inhibit some of the deleterious 
actions of reactive oxygen species that damage lipids, 
DNA and proteins. Several antioxidants, including -
tocopherol, GSH and GSH-enhancing agents (i.e. drugs 
that increase the cellular GSH level) have been found to 
exert cytoprotective activity in experimentally induced 
myocardial infarction condition. Earlier reports by Das et 
al. (2003) indicate that squalene exerts a significant 
protective action against cisplatin-induced toxicity in 
neuroblastoma cells similar to that of GSH, which is well 
known to detoxify platinum compounds by enhancing the 
GSH-GST detoxification system. It also suggests that 
squalene has a selective in vitro cytoprotective effect on 
bone marrow derived hemopoietic stem cells that is 
equipotent to GSH. The highly lipophilic squalene can 
readily pass across the PUFA rich membrane lipid bilayer 
and its ability to diffuse into intracellular compartments 
aids in it’s capabilities as a potent antioxidant (Hauβ et al.  




, 2002; Haines, 2001). 
The Group 4b animals fed with squalene + PUFA 
concentrate in the present study showed a significant 
(p<0.001) elevation in the level of GSH along with a 
marked (p<0.001) rise in the activities of superoxide 
dismutase and catalase, thus indicating the antioxidant 
nature of squalene in experimentally induced oxidative 
stress condition. There are several molecules that directly 
scavenge free radicals, including many ingested 
antioxidants such as vitamin C and E as well as β-caro-
tene. Of particular relevance to this present study, recent 
research has revealed that squalene, both endo-genous 
and exogenous, may help to neutralize free radicals 
before they can exert their destructive activity (O’Sullivan 
et al., 2002). Squalene is highly lipophilic and, when 
administered exogenously, it can readily pass across the 
cellular and subcellular membranes (Kamimura et al., 
1992). The ability of squalene to diffuse into intracellular 
compartments helps in the capabilities of this isoprenoid 
as a potent antioxidant (Kohno et al., 1995). 
Squalene has a much greater efficiency in neutralizing 
•OH than the endogenous antioxidant GSH (Das et al., 
2003). Previous studies (Saint-Leger et al., 1986; Aioi et 
al., 1995) have shown that squalene accomplishes free 
radical scavenging by a non-enzymatic process of elec-
tron donation. Catecholamines act themselves by directly 
generating free radicals from oxygen species that cause 
an immediate destruction or modification of cellular and 
subcellular functions (Lin et al., 2005; Shiny et al., 2005). 
Thus, the ability of exogenous, and partly endogenous, 
squalene to suppress the development of myocardial 
infarction processes suggests that squalene, as a strong 
component of the antioxidant defense system, helps to 
prevent myocardial infarction. 
There is an urgent need for the clinical development of 
safe and non-toxic cytoprotective agents for the manage-
ment of cardiovascular diseases. From the present 
results, it is evident that the supplementation of PUFA 
concentrate alone along with feed stimulates the forma-
tion of lipid peroxidation products, which are very much 
harmful to the structural and functional integrity of the 
myocardium. But in the case of squalene, it is observed 
that this isoprenoid antioxidant molecule supplementation 
is highly beneficial in counteracting isoprenaline-induced 
lipid peroxidation and in stabilizing the myocardial mem-
brane. Hence it is postulated that the combined supple-
mentation of squalene and PUFA concentrate may be an 
effective therapeutic option for ameliorating the myocar-
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